A detailed history of Essex Financial Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Essex Financial Services, Inc. holds 12,988 shares of NVO stock, worth $1.38 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
12,988
Previous 15,117 14.08%
Holding current value
$1.38 Million
Previous $2.16 Million 28.33%
% of portfolio
0.07%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$119.07 - $145.42 $253,500 - $309,599
-2,129 Reduced 14.08%
12,988 $1.55 Million
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $36,444 - $43,632
297 Added 2.0%
15,117 $2.16 Million
Q2 2024

Jul 31, 2024

BUY
$122.71 - $146.91 $259,286 - $310,420
2,113 Added 16.63%
14,820 $2.12 Million
Q1 2024

Apr 23, 2024

BUY
$102.11 - $135.92 $453,164 - $603,212
4,438 Added 53.67%
12,707 $1.63 Million
Q4 2023

Feb 05, 2024

BUY
$87.78 - $105.45 $119,907 - $144,044
1,366 Added 19.79%
8,269 $855,000
Q3 2023

Nov 15, 2023

BUY
$90.94 - $199.54 $314,288 - $689,610
3,456 Added 100.26%
6,903 $627,000
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $2,651 - $2,935
17 Added 0.5%
3,447 $557,000
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $3,176 - $3,819
24 Added 0.7%
3,430 $545,000
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $39,379 - $51,966
384 Added 12.71%
3,406 $460,000
Q3 2022

Nov 07, 2022

BUY
$95.28 - $116.93 $107,380 - $131,780
1,127 Added 59.47%
3,022 $301,000
Q2 2022

Aug 01, 2022

BUY
$103.24 - $121.81 $2,993 - $3,532
29 Added 1.55%
1,895 $211,000
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $178,912 - $218,471
1,866 New
1,866 $209,000
Q1 2019

May 02, 2019

SELL
$46.36 - $52.63 $200,738 - $227,887
-4,330 Closed
0 $0
Q4 2018

Feb 07, 2019

BUY
$41.54 - $47.25 $179,868 - $204,592
4,330 New
4,330 $246,000
Q3 2017

Nov 03, 2017

SELL
$41.15 - $49.22 $223,773 - $267,658
-5,438 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
5,438
5,438 $233,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Essex Financial Services, Inc. Portfolio

Follow Essex Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.